Trial intelligence / Profile preview

Cord blood serum versus autologous PRP for striae distensae

IRCT20221130056672N2Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Dec 2023
Countries
1
01

Overview

Phase 2, open-label trial of platelet-rich plasma in Striae atrophicae (SA) (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Tested groups, Type of treatment and 8 more. Started Dec 2023; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

Striae atrophicae (SA)

Beyond the preview

Go deeper on IRCT20221130056672N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221130056672N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call